Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension

International Journal of Cardiology

Volumn 266, Issue , 2018, Pages 229-235

  Tello, Khodr ^a   Axmann, Jens ^a   Ghofrani, Hossein A ^a,b,c   Naeije, Robert ^d   Narcin, Newroz ^a   Rieth, Andreas ^b   Seeger, Werner ^a   Gall, Henning ^a   Richter, Manuel J ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b Rheuma and Thoracic Center ^*  (Germany)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d ERASME HOSPITAL   (Belgium)

Author keywords

PASP; Pulmonary hypertension; Right ventricular contractile function; Survival; TAPSE

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL STATUS; HAZARD RATIO; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION PULMONARY ARTERIAL SYSTOLIC PRESSURE RATIO; AGED; BLOOD PRESSURE; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; REGISTER; RETROSPECTIVE STUDY; SYSTOLE; TRICUSPID VALVE;

ADULT; AGED; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SYSTOLE; TRICUSPID VALVE;

EID: 85048534340     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2018.01.053     Document Type: Article

References (44)

1. Galie, N., Humbert, M., Vachiery, J.L., et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 37 (2016), 67–119.
2. Harrison, A., Hatton, N., Ryan, J.J., The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover conference series). Pulm. Circ. 5 (2015), 29–47.
3. Vonk Noordegraaf, A., Westerhof, B.E., Westerhof, N., The relationship between the right ventricle and its load in pulmonary hypertension. J. Am. Coll. Cardiol. 69 (2017), 236–243.
4. Forfia, P.R., Fisher, M.R., Mathai, S.C., et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am. J. Respir. Crit. Care Med. 174 (2006), 1034–1041.
5. Naeije, R., Assessment of right ventricular function in pulmonary hypertension. Curr. Hypertens. Rep., 17, 2015, 35.
6. Guazzi, M., Bandera, F., Pelissero, G., et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am. J. Physiol. Heart Circ. Physiol. 305 (2013), H1373–1381.
7. Hussain, I., Mohammed, S.F., Forfia, P.R., et al. Impaired right ventricular-pulmonary arterial coupling and effect of sildenafil in heart failure with preserved ejection fraction: an ancillary analysis from the Phosphodiesterase-5 inhibition to improve clinical status and exercise capacity in diastolic heart failure (RELAX) trial. Circ. Heart Fail., 9, 2016, e002729.
8. Guazzi, M., Dixon, D., Labate, V., et al. RV contractile function and its coupling to pulmonary circulation in heart failure with preserved ejection fraction: stratification of clinical phenotypes and outcomes. JACC Cardiovasc. Imaging 10 ((2017), 1211–1221.
9. Gorter, T.M., van Veldhuisen, D.J., Voors, A.A., et al. Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension. Eur. Heart J. Cardiovasc. Imaging, 2017, 10.1093/ehjci/jex133.
10. Guazzi, M., Villani, S., Generati, G., et al. Right ventricular contractile reserve and pulmonary circulation uncoupling during exercise challenge in heart failure: pathophysiology and clinical phenotypes. JACC Heart Fail. 4 (2016), 625–635.
11. Guazzi, M., Naeije, R., Arena, R., et al. Echocardiography of right ventriculoarterial coupling combined with cardiopulmonary exercise testing to predict outcome in heart failure. Chest 148 (2015), 226–234.
12. Gerges, M., Gerges, C., Pistritto, A.M., et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am. J. Respir. Crit. Care Med. 192 (2015), 1234–1246.
13. Gall, H., Felix, J.F., Schneck, F.K., et al. The Giessen pulmonary hypertension registry: survival in pulmonary hypertension subgroups. J Heart Lung Transplant 36 (2017), 957–967.
14. Medrek, S.K., Kloefkorn, C., Nguyen, D.T.M., Graviss, E.A., Frost, A.E., Safdar, Z., Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension. Pulm. Circ. 7 (2017), 399–408.
15. Rudski, L.G., Lai, W.W., Afilalo, J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23 (2010), 685–713 (quiz 786-688).
16. Lang, R.M., Bierig, M., Devereux, R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18 (2005), 1440–1463.
17. Quiñones, M.A., Otto, C.M., Stoddard, M., et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards Committee of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 15 (2002), 167–184.
18. Kircher, B.J., Himelman, R.B., Schiller, N.B., Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am. J. Cardiol. 66 (1990), 493–496.
19. Kane, G.C., Maradit-Kremers, H., Slusser, J.P., Scott, C.G., Frantz, R.P., McGoon, M.D., Integration of clinical and hemodynamic parameters in the prediction of long-term survival in patients with pulmonary arterial hypertension. Chest 139 (2011), 1285–1293.
20. Peduzzi, P., Concato, J., Feinstein, A.R., Holford, T.R., Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 48 (1995), 1503–1510.
21. Benza, R.L., Miller, D.P., Gomberg-Maitland, M., et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 122 (2010), 164–172.
22. D'Alonzo, G.E., Barst, R.J., Ayres, S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann. Intern. Med. 115 (1991), 343–349.
23. Fuster, V., Steele, P.M., Edwards, W.D., Gersh, B.J., McGoon, M.D., Frye, R.L., Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70 (1984), 580–587.
24. Raymond, R.J., Hinderliter, A.L., Willis, P.W., et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J. Am. Coll. Cardiol. 39 (2002), 1214–1219.
25. Wright, L.M., Dwyer, N., Celermajer, D., Kritharides, L., Marwick, T.H., Follow-up of pulmonary hypertension with echocardiography. JACC Cardiovasc. Imaging 9 (2016), 733–746.
26. Yeo, T.C., Dujardin, K.S., Tei, C., Mahoney, D.W., McGoon, M.D., Seward, J.B., Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am. J. Cardiol. 81 (1998), 1157–1161.
27. Giavarina, D., Understanding Bland Altman analysis. Biochem. Med. (Zagreb) 25 (2015), 141–151.
28. Bellofiore, A., Dinges, E., Naeije, R., et al. Reduced haemodynamic coupling and exercise are associated with vascular stiffening in pulmonary arterial hypertension. Heart 103 (2017), 421–427.
29. Sanz, J., Garcia-Alvarez, A., Fernandez-Friera, L., et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 98 (2012), 238–243.
30. Brewis, M.J., Bellofiore, A., Vanderpool, R.R., et al. Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. Int. J. Cardiol. 218 (2016), 206–211.
31. Ghio, S., Guazzi, M., Scardovi, A.B., et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur. J. Heart Fail. 19 (2017), 873–879.
32. Bosch, L., Lam, C.S.P., Gong, L., et al. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Eur. J. Heart Fail., 2017, 10.1002/ejhf.873 (Published online ahead of print 1008 June 2017).
33. Ghio, S., Pica, S., Klersy, C., et al. Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy. Open Heart, 3, 2016, e000408.
34. Ghio, S., Klersy, C., Magrini, G., et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int. J. Cardiol. 140 (2010), 272–278.
35. Chen, L., Larsen, C.M., Le, R.J., et al. The prognostic significance of tricuspid valve regurgitation in pulmonary arterial hypertension. Clin. Respir. J., 2017, 10.1111/crj.12713 [Sep 14, Epub ahead of print].
36. Hsiao, S.H., Lin, S.K., Wang, W.C., Yang, S.H., Gin, P.L., Liu, C.P., Severe tricuspid regurgitation shows significant impact in the relationship among peak systolic tricuspid annular velocity, tricuspid annular plane systolic excursion, and right ventricular ejection fraction. J. Am. Soc. Echocardiogr. 19 (2006), 902–910.
37. Fender, E.A., Zack, C.J., Nishimura, R.A., Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart, 2017, 10.1136/heartjnl-2017-311586 [Dec 11, Epub ahead of print].
38. Badagliacca, R., Raina, A., Ghio, S., et al. Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension. J Heart Lung Transplant, 2017, 10.1016/j.healun.2017.08.009 [Aug 26, Epub ahead of print].
39. Ghio, S., D'Alto, M., Badagliacca, R., et al. Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension. Int. J. Cardiol. 230 (2017), 53–58.
40. Al-Naamani, N., Preston, I.R., Hill, N.S., Roberts, K.E., The prognostic significance of pulmonary arterial capacitance in pulmonary arterial hypertension: single-center experience. Pulm. Circ. 6 (2016), 608–610.
41. Stevens, G.R., Garcia-Alvarez, A., Sahni, S., Garcia, M.J., Fuster, V., Sanz, J., RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc. Imaging 5 (2012), 378–387.
42. Prins, K.W., Archer, S.L., Pritzker, M., et al. Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension. J Heart Lung Transplant, 2017, 10.1016/j.healun.2017.08.011.
43. Kind, T., Mauritz, G.J., Marcus, J.T., van de Veerdonk, M., Westerhof, N., Vonk-Noordegraaf, A., Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J. Cardiovasc. Magn. Reson., 12, 2010, 35.
44. Farsalinos, K.E., Daraban, A.M., Unlu, S., Thomas, J.D., Badano, L.P., Voigt, J.U., Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J. Am. Soc. Echocardiogr. 28 (2015), 1171–1181 (e1172).